Additionally, we discovered that VTX, an antidepressant known for its cognitive benefits in depression, notably counteracts the abnormal NLRP3 inflammasome expression, particularly in the dorsal hippocampus 24 h after LPS exposure, potentially via regulating NEK7 expression. The gene discussed is NLRP3; the disease is depressive symptom measurement.